CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
CTIC
Delisted
CTIC was delisted on the 23rd of June, 2023.
56 hedge funds and large institutions have $160M invested in CTI BioPharma Corp. (DE) Common Stock in 2021 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 13 increasing their positions, 15 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
13% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 15
33% less call options, than puts
Call options by funds: $287K | Put options by funds: $431K
Holders
56
Holding in Top 10
3
Calls
$287K
Puts
$431K
Top Buyers
| 1 | +$5.61M | |
| 2 | +$1.49M | |
| 3 | +$994K | |
| 4 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$979K |
| 5 |
Verition Fund Management
Greenwich,
Connecticut
|
+$464K |
Top Sellers
| 1 | -$3.88M | |
| 2 | -$1.91M | |
| 3 | -$1.5M | |
| 4 |
ACM
Altium Capital Management
New York
|
-$1.08M |
| 5 |
Two Sigma Investments
New York
|
-$598K |